It is highly probable that the prolonged, undiagnosed course of primary hyperaldosteronism was a major risk factor for the recurrent acute cerebrovascular events that resulted in the patient's permanent disability.
Abstract
Objective. The aim of the study is to demonstrate the clinical significance of the timely detection of secondary hypertension in patients with resistant hypertension and severe cardiovascular complications.
Materials and Methods. We analyzed a clinical case of a 49-year-old female patient with long-standing resistant hypertension, multiple ischemic strokes, severe hypokalemia, and target organ damage. Clinical and laboratory evaluations were performed, including measurements of aldosterone and renin levels and the aldosterone-to-renin ratio (ARR). Adrenal imaging was conducted using computed tomography (CT).
Results. The patient presented with persistent, poorly controlled hypertension despite multicomponent antihypertensive therapy, chronic severe hypokalemia. Notably, this hypokalemia had long been overlooked and had not prompted either a treatment revision or a targeted diagnostic workup. Additionally, hypernatremia, left ventricular hypertrophy, and sequelae of recurrent ischemic strokes were identified. Hormonal profiling revealed elevated aldosterone levels and an increased aldosterone-to-renin ratio. Computed tomography identified a left adrenal mass consistent with an aldosterone-producing adenoma. The patient underwent endoscopic left adrenalectomy. Postoperative outcomes included normalization of potassium levels, a decrease in aldosterone concentration, restoration of the aldosterone-to-renin ratio, and achievement of target blood pressure levels. It is highly probable that the prolonged, undiagnosed course of primary hyperaldosteronism was a major risk factor for the recurrent acute cerebrovascular events that resulted in the patient's permanent disability.
Conclusion. This case highlights a prolonged, undiagnosed course of primary hyperaldosteronism associated with severe cerebrovascular complications and subsequent disability. In routine clinical practice, timely screening for primary hyperaldosteronism using the aldosterone-to-renin ratio in comorbid patients with resistant hypertension and hypokalemia could facilitate early diagnosis and ultimately improve patient outcomes.
Primary aldosteronism (PA) is a common but frequently ignored cause of hypertension, particularly in patients with normal serum potassium and aldosterone levels. We report the case of a 70-year-old Han Chinese man with a 20-year history of hypertension who presented with normokalemia and normal plasma aldosterone level...
Yu-Wan Xu, Ke Song, Shuai Wu et al.· Journal of Medical Case Repo...· 0 citations
Objective: Primary aldosteronism (PA) is a common but frequently underdiagnosed cause of secondary hypertension, particularly in low-resource settings where access to hormonal assays and confirmatory testing is limited. Hypokalemia, although traditionally associated with PA, is absent in most cases and may suppress...
Afina Thara Pitaloka, H. Novida· Adolescência e Saúde· 0 citations
Primary Aldosteronism (PA) is postulated to represent one of the most prevalent and significant etiologies of secondary hypertension. A majority of investigations have indicated that the incidence of PA has been escalating, particularly within the cohort of normokalemic individuals. PA generally constitutes an adrenal...
Gamze Akkuş, A. Boz, T. Tetiker· Current Medicinal Chemistry· 0 citations
Renin–angiotensin–aldosterone system (RAAS) inhibitors, including angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers, were successfully incorporated into antihypertensive therapy in all cases and may be effective and safe in patients with MAH.
K. Demyanova, N. Kozlovskaya, M. Khachatryan et al.· Nephrology and Dialysis· 0 citations
Primary aldosteronism (PA) is the most common cause of secondary hypertension, characterized by autonomous aldosterone overproduction leading to hypertension, hypokalemia, and increased cardiovascular risk. Mineralocorticoid receptor antagonists (MRAs) are the pharmacological cornerstone of treatment when surgery is no...
Bianca Miato de Brito, Clara Vanini de Oliveira, Júnia Assunção e Souza et al.· Brazilian Journal of Case Re...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.